Trial Profile
A trial to study effects of early anticoagulation resumption with apixaban on the acute stroke patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2016
Price :
$35
*
At a glance
- Drugs Apixaban (Primary)
- Indications Stroke
- Focus Adverse reactions; Pharmacokinetics
- 05 Apr 2016 New trial record
- 19 Feb 2016 Results presented at the 41st International Stroke Conference